Overview
Combination Chemotherapy in Treating Patients With Stage III or Stage IV Pancreatic Cancer That Cannot Be Removed by Surgery
Status:
Completed
Completed
Trial end date:
2003-08-01
2003-08-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy in treating adult patients who have stage III or stage IV pancreatic cancer that cannot be removed by surgery.Phase:
Phase 2Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Barbara Ann Karmanos Cancer InstituteCollaborator:
National Cancer Institute (NCI)Treatments:
Cisplatin
Fluorouracil
Gemcitabine
Criteria
DISEASE CHARACTERISTICS: Histologically or cytologically confirmed pancreaticadenocarcinoma Unresectable locally advanced (stage III) OR Metastatic (stage IV)
Gallbladder or biliary tract cancer allowed No endocrine tumors or lymphoma of the pancreas
No CNS metastases
PATIENT CHARACTERISTICS: Age: Adult Performance status: SWOG 0-2 Life expectancy: At least
12 weeks Hematopoietic: Absolute neutrophil count greater than 1,500/mm3 Platelet count
greater than 100,000/mm3 Hepatic: Bilirubin no greater than 2.0 mg/dL AST no greater than
3.0 times upper limit of normal Renal: Creatinine no greater than 1.5 mg/dL Other: No
active infection No other serious systemic disorders No other active malignancies within
the past year except curatively treated basal cell skin cancer or carcinoma in situ of the
cervix Must have central venous access device (i.e., Infusaport or PASPORT) Not pregnant or
nursing Fertile patients must use effective contraception
PRIOR CONCURRENT THERAPY: Biologic therapy: Not specified Chemotherapy: No prior
chemotherapy for locally advanced or metastatic disease At least 6 months since prior
adjuvant chemotherapy No prior gemcitabine Endocrine therapy: Not specified Radiotherapy:
Not specified Surgery: See Disease Characteristics